Retention of graft-versus-leukemia using selective depletion of CD8-positive T lymphocytes for prevention of graft-versus-host disease following bone marrow transplantation for chronic myelogenous leukemia
Champlin, R.; Jansen, J.; Ho, W.; Gajewski, J.; Nimer, S.; Lee, K.; Territo, M.; Winston, D.; Tricot, G.; Reichert, T.
Transplantation Proceedings 23(1 Pt 2): 1695-1696
1991
ISSN/ISBN: 0041-1345 PMID: 1899162 Document Number: 373521
Document emailed within 1 workday
Related Documents
Champlin, R. 1992: Graft-versus-leukemia without graft-versus-host disease: an elusive goal of bone marrow transplantation Seminars in Hematology 29(3 Suppl 2): 46-52Haanen, C.; De Witte, T.; Plas, A.; Schattemberg, T. 1991: Prevention of graft-versus-host disease by lymphocyte depletion of the bone marrow graft with use of counterflow centrifugation Haematologica 76 Suppl. 1: 22-28
Bacigalupo, A.; Frassoni, F.; Van Lint, M.T.; Occhini, D.; Gualandi, F.; Lamparelli, T.; Vitale, V.; Scarpati, D.; Clavio, M.; Marmont, A.M. 1989: Allogeneic bone marrow transplantation in acute and chronic myeloid leukemia: role of conditioning and of graft-versus-host disease in the long-term maintenance of remission Haematologica 74(5 Suppl): 425-432
Sakamoto, K.; Sachs, D.H.; Shimada, S.; Popitz-Bergez, F.A.; Pennington, L.R.; Pescovitz, M.D.; McDonough, M.A.; MacVittie, T.J.; Katz, S.I.; Gress, R.E. 1988: Bone marrow transplantation in miniature swine. III. Graft-versus-host disease and the effect of T cell depletion of marrow Transplantation 45(5): 869-875
Atkinson, K.; Downs, K. 1995: Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation Bone Marrow Transplantation 16(6): 755-758
Moussalem, M.; Esperou Bourdeau, H.; Devergie, A.; Baruchel, A.; Ribaud, P.; Socie, G.; Parquet, N.; Traineau, R.; Hirsch, I.; Schaison, G. 1995: Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease Bone Marrow Transplantation 15(6): 943-947
Apperley, J.F.; Jones, L.; Hale, G.; Waldmann, H.; Hows, J.; Rombos, Y.; Tsatalas, C.; Marcus, R.E.; Goolden, A.W.; Gordon-Smith, E.C. 1986: Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse Bone Marrow Transplantation 1(1): 53-66
Fauser, A.A.; Shustik, C.; Langleben, A.; Laurent, G.; Kanz, L.; Spurll, G.M.; Price, G.; Ahlgren, P.D.; Cooper, B.A. 1988: T-cell depletion with ricin A-chain T101 in allogeneic bone marrow transplantation to prevent severe graft-versus-host disease Clinical and Investigative Medicine. Medecine Clinique et Experimentale 11(1): 40-46
Chowdhury, N.C.; Jin, M.X.; Hardy, M.A.; Oluwole, S.F. 1993: Prevention of graft-versus-host disease after bone marrow and small bowel transplantation by ultraviolet B modulation of bone marrow cells Transplantation Proceedings 25(1 Pt 1): 475-476
de Witte, T.; Janssen, J.; de Pauw, B.; Holdrinet, R.; Wessels, J.; Haanen, C. 1986: Prevention of graft-vs-host disease following allogeneic bone marrow transplantation Nederlands Tijdschrift Voor Geneeskunde 130(28): 1290-1291
Lin, Y.T.; Lin, D.T.; Jou, S.T.; Lin, K.S.; Lin, K.H. 1997: Allogeneic bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in childhood Journal of the Formosan Medical Association 96(5): 320-324
Ushiyama, C.; Hirano, T.; Miyajima, H.; Okumura, K.; Ovary, Z.; Hashimoto, H. 1995: Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease Journal of Immunology 154(6): 2687-2696
Antin, J.H.; Bierer, B.E.; Smith, B.R.; Guinan, E.C.; Provost, M.M.; Ferrara, J.; Macklis, R.M.; Tarbell, N.J.; Blythman, H.; Bouloux, C. 1990: Depletion of bone marrow T-lymphocytes with an anti-CD5 monoclonal immunotoxin (ST-1 immunotoxin): effective prophylaxis for graft-versus-host disease Progress in Clinical and Biological Research 333: 207-215
Reiffers, J.; Goldman, J.; Meloni, G.; Cahn, J.Y.; Gratwohl, A. 1994: Autologous stem cell transplantation in chronic myelogenous leukemia: a retrospective analysis of the European Group for Bone Marrow Transplantation. Chronic Leukemia Working Party of the EBMT Bone Marrow Transplantation 14(3): 407-410
Bishara, A.; Amar, A.; Brautbar, C.; Condiotti, R.; Lazarovitz, V.; Nagler, A. 1995: The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT) Experimental Hematology 23(14): 1667-1675
Santos, G.W. 1988: Problems and strategies for bone marrow transplantation in acute leukemia and chronic myelogenous leukemia Cancer Detection and Prevention 12(1-6): 589-596
Slavin, S.; Or, R.; Cividalli, G.; Brautbar, C.; Hale, G.; Waldmann, H.; Rachmilewitz, E. 1988: Bone marrow transplantation in beta-thalassemia major with prevention of graft-vs-host disease Birth Defects Original Article Series 23(5b): 313-316
Devergie, A.; Esperou, H.; Traineau, R.; Varrin, F.; Lehn, P.; Gluckman, E. 1989: Role of immunosuppressive drugs for prevention of graft-v-host disease after bone marrow transplantation Nouvelle Revue Francaise d'Hematologie 31(2): 73-75
Kloosterman, T.C.; Tielemans, M.J.; Martens, A.C.; van Bekkum, D.W.; Hagenbeek, A. 1994: Quantitative studies on graft-versus-leukemia after allogeneic bone marrow transplantation in rat models for acute myelocytic and lymphocytic leukemia Bone Marrow Transplantation 14(1): 15-22
Aizawa, S.; Kamisaku, H.; Sado, T. 1998: Possible induction of graft-versus-leukemia effect against a leukemia refractory to antileukemia response in ordinary MHC-compatible, allogeneic bone marrow transplantation Transplantation 65(7): 893-898